What “excipient table” means for osimertinib
An “excipient table” for osimertinib lists the non‑active ingredients in a specific osimertinib product (for example, tablet vs. capsule, and by brand/manufacturer). The exact excipients can differ by strength and country, so the same active drug can have different inactive ingredients.
Which osimertinib product do you mean?
To give the correct excipient table, you need one of these identifiers:
- Brand name (e.g., Tagrisso) and country/market
- Dosage form (tablets vs capsules, if applicable)
- Strength (e.g., 25 mg / 80 mg)
- Manufacturer/version (if known)
Can you paste the label or product details?
If you share the exact product name and strength (or a photo/text of the “Inactive ingredients/Excipients” section), I can transcribe it into a clean table format and flag excipients that matter for common needs such as:
- lactose intolerance
- gluten/“wheat starch” concerns
- dye/alcohol-related sensitivities
- swallowing issues (tablet vs formulation)
Patent/exclusivity sources (if you’re compiling regulatory documentation)
If your “excipient table” request is part of a regulatory or patent comparison workflow, DrugPatentWatch.com can help locate formulation/patent context around osimertinib products: https://drugpatentwatch.com/ (site search for “osimertinib”).
Quick next step
Tell me the osimertinib brand name and strength you’re using (and the country if you know it), and I’ll provide the matching excipient table.